Basis: Latest reported fiscal year. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is 22.88 as of Sunday, July 26, 2026.
Forward PE Ratio (22.88) = Close Price ($138.57) / Consensus Forward EPS ($6.06)
FORWARD PE RATIO
22.88
SECTOR MEDIAN · HEALTHCARE
18.38
median of 68 covered companies
CURRENT VS SECTOR MEDIAN
+24.45%
vs the sector median at left
Agilent Technologies, Inc.
Market Cap
$39.14B
Forward PE Ratio
22.88
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Agilent Technologies, Inc. (A) | $39.14B | 22.88 |
| Alnylam Pharmaceuticals, Inc. (ALNY)vs › | $36.28B | 36.45 |
| IDEXX Laboratories, Inc. (IDXX)vs › | $42.94B | 37.15 |
| IQVIA Holdings Inc. (IQV)vs › | $34.72B | 16.24 |
| Medline Inc. (MDLN)vs › | $32.77B | 25.58 |
| Zoetis Inc. (ZTS)vs › | $31.59B | 10.95 |
| Humana Inc. (HUM)vs › | $46.74B | 43.48 |
| Centene Corp. (CNC)vs › | $31.31B | 18.05 |
| Edwards Lifesciences Corporation (EW)vs › | $47.58B | 27.52 |
| Biogen Inc. (BIIB)vs › | $29.85B | 15.59 |
Trailing P/E
27.8
reported TTM EPS
Forward P/E
22.9
consensus next-FY EPS
The gap between the two multiples is the consensus growth expectation: analysts' forward EPS of $6.06 implies +21.7% EPS growth vs the reported trailing $4.98.
At today's $138.57 close, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2026-10-31 | $6.06 | $5.95 – $6.11 | 12 | 22.9x |
| 2027-10-31 | $6.60 | $6.45 – $6.68 | 13 | 21.0x |
| 2028-10-31 | $7.32 | $6.82 – $7.93 | 6 | 18.9x |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
